Your browser doesn't support javascript.
loading
Role of the gut microbiome for cancer patients receiving immunotherapy: Dietary and treatment implications.
Lee, Karla A; Shaw, Heather M; Bataille, Veronique; Nathan, Paul; Spector, Tim D.
Affiliation
  • Lee KA; Department of Twin Research and Genetic Epidemiology, King's College London, London, UK; Department of Medical Oncology, Mount Vernon Hospital, Northwood, UK; Department of Medical Oncology, The Royal Marsden, London, UK. Electronic address: karla.lee@kcl.ac.uk.
  • Shaw HM; Department of Medical Oncology, Mount Vernon Hospital, Northwood, UK; Early Phase Trial Unit, Department of Medical Oncology, University College London Hospital, London, UK.
  • Bataille V; Department of Twin Research and Genetic Epidemiology, King's College London, London, UK; Department of Dermatology, Mount Vernon Hospital, Northwood, UK.
  • Nathan P; Department of Medical Oncology, Mount Vernon Hospital, Northwood, UK.
  • Spector TD; Department of Twin Research and Genetic Epidemiology, King's College London, London, UK.
Eur J Cancer ; 138: 149-155, 2020 10.
Article in En | MEDLINE | ID: mdl-32889369
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Bacteria / Diet / Gastrointestinal Microbiome / Immune Checkpoint Inhibitors / Immunotherapy / Neoplasms Type of study: Clinical_trials / Observational_studies Language: En Journal: Eur J Cancer Year: 2020 Type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Bacteria / Diet / Gastrointestinal Microbiome / Immune Checkpoint Inhibitors / Immunotherapy / Neoplasms Type of study: Clinical_trials / Observational_studies Language: En Journal: Eur J Cancer Year: 2020 Type: Article